UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of Registrant as Specified in its Charter)
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
|
|
(Address of Principal Executive Offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On February 2, 2024, Predictive Oncology Inc. (the “Company”) and Pamela Bush, Ph.D., MBA, the Company’s Chief Business Officer, agreed that Dr. Bush will leave the Company effective February 15, 2024. The Company has initiated a search to fill this function, which is consistent with its broader corporate development strategy.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PREDICTIVE ONCOLOGY inc.
| ||
Date: February 8, 2024 | By: | /s/ Josh Blacher |
Name: Josh Blacher Title: Chief Financial Officer |
Cover |
Feb. 02, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Feb. 02, 2024 |
Entity File Number | 001-36790 |
Entity Registrant Name | Predictive Oncology Inc. |
Entity Central Index Key | 0001446159 |
Entity Tax Identification Number | 33-1007393 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 91 43rd Street |
Entity Address, Address Line Two | Suite 110 |
Entity Address, City or Town | Pittsburgh |
Entity Address, State or Province | PA |
Entity Address, Postal Zip Code | 15201 |
City Area Code | (412) |
Local Phone Number | 432-1500 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, $0.01 par value |
Trading Symbol | POAI |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Entity Information, Former Legal or Registered Name | Not Applicable |
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end